David McIntosh: African Healthcare and European Partnerships in Plasma Medicine
David McIntosh, Founder and Chair of United Plasma Action, shared European Medicines Agency’s post on LinkedIn, adding:
”This welcome news must surely be a great encouragement to all who are concerned with – or about – African Healthcare matters.
I repost it here mainly for that reason.
However, a cautionary footnote is also advisable.
European Healthcare and Pharmaceuticals are well advanced, of course, and there’s much there from which others can learn, and benefit. There are some aspects of European practice, policy and folklore that are less valuable. Some are positively counter-productive.
Africa will therefore do well to approach all European partnerships with both optimism and caution.
In a specific example – the European approach to plasma-derived medicines is backward and unproductive. It would not be a good rôle model for Africa to follow.
The Continent of Europe is heavily dependent on US plasma to meet the needs of European patients.
European countries following the ‘party line’ on plasma collection/donation are all failing to meet their own patients’ needs.
None are generating any surplus to export for the benefit of others.
In the plasma medicines field, Africa should beware of Europeans bearing gifts.”
Quoting European Medicines Agency’s post:
”The African Medicines Agency (AMA) officially opened its doors in Kigali, Rwanda, marking a major milestone for strengthening regulatory systems across the continent.
The agency is committed to enhancing collaboration among National Regulatory Authorities (NRAs) across Africa and improve patients’ access to safe, quality, and efficacious medical products.
EMA, together with the European medicines regulatory network, has supported the African Union in establishing the agency through guidance, technical expertise, and financial support to help bring the African Medicines Agency to life. EMA’s support is part of the MAV plus (Manufacturing and Access to Vaccines, Medicines and Health Technologies) initiative, a Global Gateway flagship project.
In our new video, you can hear from Emer Cooke and Dr Delese Mimi Darko, leaders of their respective agencies, as they share insights into this unique partnership and the first weeks of AMA in action.”
Proceed to the video attached to the post.
Other posts featuring David McIntosh on Hemostasis Today.
-
May 18, 2026, 14:47Ting Yuan: Understanding the Complexity Behind Repeated IVF Failure
-
May 18, 2026, 14:33Global Resolution on Advancing Comprehensive Care and Health Equity for People with Bleeding Disorders Worldwide at the 79th WHA – WFH
-
May 18, 2026, 14:25Salih Ehsan: Key Diagnostic Clues in Thalassemia Minor
-
May 18, 2026, 14:02Matteo Foschi: A Global Gathering for Stroke Innovation and Research at ESOC 2026
-
May 18, 2026, 14:01Who is the NBA? – Haemophilia Foundation Australia
-
May 18, 2026, 14:00Julie Makani: Partnership between Tanzania and the USA – Health Sciences
-
May 18, 2026, 13:58Alejandro González Veliz: Cardiology Enters the Era of Inflammation
-
May 18, 2026, 13:50Arshad-Ali Auhammad: Celebrating Youth Leadership in the Global Bleeding Disorders Community
-
May 18, 2026, 13:36Zain Khalpey: In Cardiovascular Medicine Flow Is Everything